← Search & browse all drugs

pramiracetam

N06BX16

Forms & Strengths

Oral capsules: 300 mg
Oral tablets: 600 mg
Bulk powder

Adult Dosing

Cognitive enhancement/memory: 600 mg to 1200 mg orally twice daily
Total daily dose typically ranges from 1200 mg to 2400 mg divided in 2-3 doses

Pediatric Dosing

Safety and efficacy not established in pediatric patients
Not recommended for use in children or adolescents

Indications

Off-label: Cognitive enhancement and memory improvement
Investigational: Treatment of memory deficits associated with neurodegenerative conditions, brain injury, or cognitive decline

Mechanism of Action

Potent high-affinity choline uptake (HACU) enhancer in the hippocampus
Increases acetylcholine synthesis and neurotransmission
Modulates AMPA-type glutamate receptors, facilitating long-term potentiation (LTP)

Contraindications

Hypersensitivity to pramiracetam or any component of the formulation
Severe renal impairment (due to lack of safety data and clearance pathway)
Severe hepatic impairment

Adverse Reactions

Headache
Gastrointestinal distress (nausea, abdominal discomfort)
Dizziness or nervousness
Insomnia or sleep disturbances
Fatigue

Drug Interactions

Anticholinergic agents: May antagonize the effects of acetylcholine precursors/enhancers
Cholinergic agents: Potential additive pharmacodynamic effects and increased risk of cholinergic side effects
No significant cytochrome P450 enzyme induction or inhibition reported

Curated Content: Needs Vetting Before Put to Clinical Use